About BioNTech
BioNTech is a company based in Mainz (Germany) founded in 2008 by Christoph Huber and Ozlem Tureci.. BioNTech has raised $805.99 million across 12 funding rounds from investors including Fidelity Investments, Mirae Asset and Sanofi. The company has 6,770 employees as of December 31, 2024. BioNTech has completed 5 acquisitions, including Biotheus, CureVac and InstaDeep. BioNTech offers products and services including COMIRNATY and mRNA Cancer Immunotherapies. BioNTech operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others.
- Headquarter Mainz, Germany
- Employees 6770 as on 31 Dec, 2024
- Founders Christoph Huber, Ozlem Tureci
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biontech Se Sponsored Adr
-
Annual Revenue
$2.98 B-27.92as on Dec 31, 2024
-
Net Profit
$-719.65 M-171.55as on Dec 31, 2024
-
EBITDA
$-373.62 M-131.73as on Dec 31, 2024
-
Total Equity Funding
$805.99 M (USD)
in 12 rounds
-
Latest Funding Round
$150 M (USD), Post-IPO
Apr 14, 2022
-
Investors
Fidelity Investments
& 18 more
-
Employee Count
6770
as on Dec 31, 2024
-
Investments & Acquisitions
Biotheus
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioNTech
BioNTech is a publicly listed company on the NASDAQ with ticker symbol BNTX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioNTech
BioNTech offers a comprehensive portfolio of products and services, including COMIRNATY and mRNA Cancer Immunotherapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
mRNA vaccine for preventing COVID-19 infections
Immunotherapies targeting cancer cells via mRNA technology
Unlock access to complete
Unlock access to complete
Leadership Team
124 people
Software Development Team
124 people
Operations Team
29 people
Legal and Compliance
28 people
Product Management Team
28 people
Human Resources and Administration
23 people
Data Analysis and Operations Team
14 people
Sales and Marketing
12 people
Unlock access to complete
Funding Insights of BioNTech
BioNTech has successfully raised a total of $805.99M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $150 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $150.0M
- First Round First Round
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Post-IPO - BioNTech | Valuation |
investors |
|
| Sep, 2020 | Amount | Post-IPO - BioNTech | Valuation |
investors |
|
| Jun, 2020 | Amount | Post-IPO - BioNTech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioNTech
BioNTech has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Mirae Asset and Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Jebsen Capital is engaged in multi-strategy investments for Jebsen Group.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioNTech
BioNTech has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Biotheus, CureVac and InstaDeep. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of antibody-based therapeutics for cancer treatment
|
2018 | ||||
|
Alternatives to antibiotics are developed via phage therapy expertise.
|
2016 | ||||
|
AI and cloud-based automation solutions are provided for organizational optimization.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - BioNTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biontech Comparisons
Competitors of BioNTech
BioNTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biontech
Frequently Asked Questions about BioNTech
When was BioNTech founded?
BioNTech was founded in 2008.
Where is BioNTech located?
BioNTech is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.
Is BioNTech a funded company?
BioNTech is a funded company, having raised a total of $805.99M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $250M, raised on Jun 01, 2008.
How many employees does BioNTech have?
As of Dec 31, 2024, the latest employee count at BioNTech is 6,770.
What is the annual revenue of BioNTech?
Annual revenue of BioNTech is $2.98B as on Dec 31, 2024.
What does BioNTech do?
BioNTech was established in 2008 in Mainz, Germany, within the biotechnology sector. Immunotherapeutics targeting cancer and additional diseases are developed, with an oncology pipeline encompassing mRNA-based treatments, modified cell therapies, antibodies, and small molecule immunomodulators. Optimization for specific action mechanisms, precise targeting, potency, and efficacy is emphasized in these efforts. Operations center on advancing therapeutic innovations for clinical applications.
Who are the top competitors of BioNTech?
BioNTech's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does BioNTech offer?
BioNTech offers COMIRNATY and mRNA Cancer Immunotherapies.
Is BioNTech publicly traded?
Yes, BioNTech is publicly traded on NASDAQ under the ticker symbol BNTX.
How many acquisitions has BioNTech made?
Who are BioNTech's investors?
BioNTech has 19 investors. Key investors include Fidelity Investments, Mirae Asset, Sanofi, Fosun Pharmaceutical, and Gates Foundation.
What is BioNTech's ticker symbol?
The ticker symbol of BioNTech is BNTX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.